Cessation of Nucleos(t)ide Analogue Therapy in Non-Cirrhotic Hepatitis B Patients with Prior Severe Acute Exacerbation
Chronic hepatitis B (CHB) with severe acute exacerbation (SAE) is an urgent problem requiring nucleos(t)ide analogue (NA) therapy. We aim to evaluate the clinical relapse (CR) risk after discontinuing NA in patients with prior SAE. Methods: In this retrospective cohort study, CHB patients who discon...
Enregistré dans:
Auteurs principaux: | Chia-Yeh Lai, Sheng-Shun Yang, Shou-Wu Lee, Hsin-Ju Tsai, Teng-Yu Lee |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/6eda9f4774af474585feb9d310c061d1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
NEW METHOD FOR DETERMINING HEPATITIS B VIRUS RESISTANCE MUTATIONS M204I/V TO NUCLEOS(T)IDE ANALOGUES IN PATIENTS WITH CHRONIC HEPATITIS B
par: E. A. Elpaeva, et autres
Publié: (2015) -
Hepatitis aguda por virus C: reporte de siete casos en centro de referencia en Chile
par: Urzúa,Álvaro, et autres
Publié: (2020) -
Effects of rituximab dose on hepatitis B reactivation in patients with resolved infection undergoing immunologic incompatible kidney transplantation
par: Juhan Lee, et autres
Publié: (2018) -
Ultra-long-acting (XLA) antivirals for chronic viral hepatitis
par: Vicente Soriano, et autres
Publié: (2022) -
Transmisión vertical de hepatitis B: Importancia de incorporar el cribado en el control prenatal en Chile
par: Castro V.,Rocío, et autres
Publié: (2021)